The incidental cystic pancreas mass: a practical approach.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 414, doi. 10.1102/1470-7330.2012.9054
- By:
- Publication type:
- Article
Works matching IS 17405025 AND DT 2012 AND VI 12 AND IP 2
Results: 18
1
2
Solitary bone lesions: which ones to worry about?
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 409, doi. 10.1102/1470-7330.2012.9049
- By:
- Publication type:
- Article
3
Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 403, doi. 10.1102/1470-7330.2012.9048
- By:
- Publication type:
- Article
4
Therapy response with diffusion MRI: an update.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 395, doi. 10.1102/1470-7330.2012.9047
- By:
- Publication type:
- Article
5
Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation of liver tumours.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 387, doi. 10.1102/1470-7330.2012.9038
- By:
- Publication type:
- Article
6
Incidental solid cystic renal lesion.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 385, doi. 10.1102/1470-7330.2012.9034
- By:
- Publication type:
- Article
7
That liver lesion on MDCT in the oncology patient: is it important?
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 373, doi. 10.1102/1470-7330.2012.9028
- By:
- Publication type:
- Article
8
Non-invasive diagnosis of focal liver lesions: an individualized approach.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 365, doi. 10.1102/1470-7330.2012.9025
- By:
- Publication type:
- Article
9
Liver-specific contrast agents.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 363, doi. 10.1102/1470-7330.2012.9022
- By:
- Publication type:
- Article
10
Ablation of lung tumours.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 361, doi. 10.1102/1470-7330.2012.9016
- By:
- Publication type:
- Article
11
Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 351, doi. 10.1102/1470-7330.2012.9015
- By:
- Publication type:
- Article
12
Imaging beyond RECIST: CT and MRI in molecular therapies.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 347, doi. 10.1102/1470-7330.2012.9013
- By:
- Publication type:
- Article
13
RECIST rules.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 345, doi. 10.1102/1470-7330.2012.9011
- By:
- Publication type:
- Article
14
Multiparametric PET/CT in oncology.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 336, doi. 10.1102/1470-7330.2012.9007
- By:
- Publication type:
- Article
15
FDG-PET/CT based response-adapted treatment.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 324, doi. 10.1102/1470-7330.2012.9006
- By:
- Publication type:
- Article
16
Should positron emission tomography/computed tomography be the first rather than the last test performed in the assessment of cancer?
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 315, doi. 10.1102/1470-7330.2012.9005
- By:
- Publication type:
- Article
17
New ways of assessing ovarian cancer response: metabolic imaging and beyond.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 310, doi. 10.1102/1470-7330.2012.9004
- By:
- Publication type:
- Article
18
Recent advances in systemic treatments for ovarian cancer.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 305, doi. 10.1102/1470-7330.2012.9002
- By:
- Publication type:
- Article